Frank Morich serves as Executive at Cue Biopharma, Inc., where they oversee executive responsibilities. Since joining the company, Frank Morich has executed 1 insider transactions totaling $105.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 27, 2022 involved purchasing 28,000 shares valued at $105.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| May 27, 2022 | CUE | $105.0K | Purchase | 28,000 | $3.75 | Discretionary |
Frank Morich currently holds 28,000 shares of Cue Biopharma, Inc. (CUE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Frank Morich has been a net buyer of CUE stock. They have purchased $105.0K and sold $0 worth of shares.
Frank Morich's most recent insider trade was on May 27, 2022, when they purchased 28,000 shares at $3.75 per share.
Get notified when new Form 4 filings are submitted